Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 12
Results: 42
Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4415, doi. 10.1007/s00262-023-03577-2
- By:
- Publication type:
- Article
Correction to: A modified immune cell infiltration score achieves ideal stratification for CD8<sup>+</sup> T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4399, doi. 10.1007/s00262-023-03574-5
- By:
- Publication type:
- Article
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4385, doi. 10.1007/s00262-023-03573-6
- By:
- Publication type:
- Article
Organ-on-a-chip models for development of cancer immunotherapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3971, doi. 10.1007/s00262-023-03572-7
- By:
- Publication type:
- Article
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4367, doi. 10.1007/s00262-023-03571-8
- By:
- Publication type:
- Article
A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIs.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4355, doi. 10.1007/s00262-023-03570-9
- By:
- Publication type:
- Article
GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4337, doi. 10.1007/s00262-023-03569-2
- By:
- Publication type:
- Article
The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3953, doi. 10.1007/s00262-023-03568-3
- By:
- Publication type:
- Article
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4323, doi. 10.1007/s00262-023-03567-4
- By:
- Publication type:
- Article
Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3939, doi. 10.1007/s00262-023-03566-5
- By:
- Publication type:
- Article
Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren's syndrome.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4309, doi. 10.1007/s00262-023-03565-6
- By:
- Publication type:
- Article
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4293, doi. 10.1007/s00262-023-03564-7
- By:
- Publication type:
- Article
BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4279, doi. 10.1007/s00262-023-03563-8
- By:
- Publication type:
- Article
Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4261, doi. 10.1007/s00262-023-03562-9
- By:
- Publication type:
- Article
Esophageal cancer cell-derived small extracellular vesicles decrease circulating Tfh/Tfr via sEV-PDL1 to promote immunosuppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4249, doi. 10.1007/s00262-023-03561-w
- By:
- Publication type:
- Article
The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4235, doi. 10.1007/s00262-023-03560-x
- By:
- Publication type:
- Article
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3931, doi. 10.1007/s00262-023-03559-4
- By:
- Publication type:
- Article
The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4221, doi. 10.1007/s00262-023-03558-5
- By:
- Publication type:
- Article
Evaluation of neoadjuvant chemotherapy combined with PD-1 inhibitors in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma: a comparative study of antitumor activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4209, doi. 10.1007/s00262-023-03557-6
- By:
- Publication type:
- Article
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4195, doi. 10.1007/s00262-023-03556-7
- By:
- Publication type:
- Article
Cholesterol induction in CD8<sup>+</sup> T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4441, doi. 10.1007/s00262-023-03555-8
- By:
- Publication type:
- Article
A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4179, doi. 10.1007/s00262-023-03554-9
- By:
- Publication type:
- Article
Tumor immunology meets oncology (TIMO) XVII, April 20–22 2023 in Halle/Saale, Germany.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4431, doi. 10.1007/s00262-023-03553-w
- By:
- Publication type:
- Article
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4169, doi. 10.1007/s00262-023-03552-x
- By:
- Publication type:
- Article
Human anaerobic microbiome: a promising and innovative tool in cancer prevention and treatment by targeting pyruvate metabolism.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3919, doi. 10.1007/s00262-023-03551-y
- By:
- Publication type:
- Article
PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4161, doi. 10.1007/s00262-023-03550-z
- By:
- Publication type:
- Article
Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3895, doi. 10.1007/s00262-023-03549-6
- By:
- Publication type:
- Article
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4145, doi. 10.1007/s00262-023-03548-7
- By:
- Publication type:
- Article
Apolipoprotein C-III itself stimulates the Syk/cPLA2-induced inflammasome activation of macrophage to boost anti-tumor activity of CD8<sup>+</sup> T cell.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4123, doi. 10.1007/s00262-023-03547-8
- By:
- Publication type:
- Article
A modified immune cell infiltration score achieves ideal stratification for CD8<sup>+</sup> T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4103, doi. 10.1007/s00262-023-03546-9
- By:
- Publication type:
- Article
Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4089, doi. 10.1007/s00262-023-03545-w
- By:
- Publication type:
- Article
Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4077, doi. 10.1007/s00262-023-03544-x
- By:
- Publication type:
- Article
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4065, doi. 10.1007/s00262-023-03543-y
- By:
- Publication type:
- Article
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4457, doi. 10.1007/s00262-023-03542-z
- By:
- Publication type:
- Article
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4049, doi. 10.1007/s00262-023-03541-0
- By:
- Publication type:
- Article
Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4031, doi. 10.1007/s00262-023-03537-w
- By:
- Publication type:
- Article
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4015, doi. 10.1007/s00262-023-03535-y
- By:
- Publication type:
- Article
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4001, doi. 10.1007/s00262-023-03534-z
- By:
- Publication type:
- Article
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3985, doi. 10.1007/s00262-023-03530-3
- By:
- Publication type:
- Article
PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3875, doi. 10.1007/s00262-023-03520-5
- By:
- Publication type:
- Article